Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Acta Neuropathologica
|
October 6, 2022
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
Zhichao Wu, Sharika Rajan, Hye-Jung Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma
Sara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology Advances
|
January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2026
Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Neuro-Oncology
|
April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Benjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial
Byram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Cancer Cell
|
September 3, 2013
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma
Krishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, et al.
Research Square
|
September 28, 2021
Impact of the COVID-19 pandemic on exercise habits among cancer patients
Caroline Himbert, Cassandra A Hathaway, Bailee Daniels, et al.
Nature Medicine
|
July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Acta Neuropathologica
|
October 6, 2022
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
Zhichao Wu, Sharika Rajan, Hye-Jung Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma
Sara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology Advances
|
January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2026
Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Neuro-Oncology
|
April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Benjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial
Byram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Cancer Cell
|
September 3, 2013
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma
Krishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, et al.
Research Square
|
September 28, 2021
Impact of the COVID-19 pandemic on exercise habits among cancer patients
Caroline Himbert, Cassandra A Hathaway, Bailee Daniels, et al.
Nature Medicine
|
July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Page
of 16